InvestorsHub Logo
icon url

Bright Boy

01/13/22 4:12 PM

#434846 RE: trocprofit #434840

No long waiting list because the process is not approved and too expensive without government subsidies!!

Most people cannot afford a $250K procedure. Without approvals, no insurance and no gov. help so those people just go home and die!!!

DCVax-L should be approved world wide right now as a humanitarian effort!!!For God's sake,
these patients in need are being jerked around by jerks in the RA's that have no concern for human life other than their own!!!

Cheers only to those that agree ,

BB
icon url

ae kusterer

01/13/22 5:52 PM

#434866 RE: trocprofit #434840

If the efficacy in the paper is strong , how many newly diagnosed GBM patients annually, on a global basis , would be willing to travel to Sawston to have a 1/3 shot at 7-8 years MOS.
icon url

sharpie510

01/13/22 6:30 PM

#434872 RE: trocprofit #434840

Even when the UK Specials only had the London clean room making 4-6 patient batches per month, there already was/is a long waiting list according to people trying to access DCVax-L. If Sawston phase 1a can bring capacity to 45-50 per month, there will undoubtedly be demand, but we'll have to see if it causes another backlog of patients trying to get the vaccine due to needing to pay out of pocket. My feeling is people with no viable option will do whatever it takes to raise the funds. I know I would. And if positive TLD is coming in a matter of weeks, NWBO is well aware they will need to ramp quickly to meet the demand especially if DCVax-L becomes a new standard of care for glioblastoma.

https://www.prnewswire.com/news-releases/northwest-biotherapeutics-announces-mhra-approval-of-license-for-gmp-manufacturing-at-sawston-uk-facility-301449083.html